Skip to main content
NANOVEU LIMITED logo

NANOVEU LIMITED — Investor Relations & Filings

Ticker · NVU ISIN · AU0000024796 LEI · 5299003PDOQ5DPU98119 ASX Manufacturing
Open in API
Filings indexed 627 across all filing types
Latest filing 2021-03-22 Regulatory Filings
Country AU Australia
Listing ASX NVU

About NANOVEU LIMITED

https://nanoveu.com/

Nanoveu Limited specializes in the development of advanced materials and digital imaging solutions through nanotechnology. The company’s product portfolio includes EyeFly3D, a specialized film and software platform that enables glasses-free 3D visualization on mobile devices. Its Nanoshield product line features antimicrobial coatings and films that utilize copper ions to eliminate pathogens on frequently touched surfaces. Furthermore, the company is advancing EyeFyx technology, which aims to provide vision correction for individuals with presbyopia by manipulating digital screen output. Nanoveu focuses on integrating proprietary thin-film coatings with sophisticated algorithms to enhance display functionality and provide protective surface treatments across various consumer and commercial applications.

Recent filings

Filing Released Lang Actions
Exclusive Distribution Agreement for the Philippines 3 pages 136.0KB
Regulatory Filings Classification · 95% confidence The document is an ASX release announcing an exclusive distribution agreement for the Philippines market. It details the terms of the agreement, the parties involved, and the strategic rationale behind the deal. There are no financial statements, quarterly or annual results, or detailed financial analysis present. The document is a corporate announcement about a commercial agreement rather than a financial report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Capital/Financing Update. It is a typical corporate news release about a business development, which aligns best with the Regulatory Filings (RNS) category as a general announcement that does not fit other specific categories.
2021-03-22 English
International Distribution Agreements Accelerate 3 pages 145.4KB
Capital/Financing Update Classification · 95% confidence The document is an ASX release dated 11 March 2021 from Nanoveu Limited announcing new international distribution agreements for their antiviral protection products. It details the terms of the agreements, the companies involved, and the strategic rationale behind these partnerships. There is no financial data, no mention of quarterly or annual results, no discussion of management changes, no voting results, and no legal proceedings. The content focuses on business development and capitalizing on sales channels, which aligns with updates on company fundraising, financing activities, or capital structure changes. Therefore, the document fits best under Capital/Financing Update (CAP). The document length is 6892 characters, which is sufficient for a substantive announcement but not a full financial report.
2021-03-10 English
Preliminary Final Report 3 pages 226.5KB
Report Publication Announcement Classification · 95% confidence The document is titled 'Appendix 4E Preliminary final report' and references the financial period ended 31 December 2020, with comparative data for 2019. It includes key financial results such as revenue, loss, and loss per share, as well as a brief explanation of results and operational highlights. The document also mentions that the financial statements contained in the annual report have been audited and refers to the attached Annual Report for further details. The length of the document is 3651 characters, which is relatively short and includes a summary of financial results rather than full financial statements. The document is primarily an announcement of the preliminary final results and refers readers to the full Annual Report for detailed financial information. According to the 'Menu vs Meal' rule, since this document is short and refers to the Annual Report being attached, it should be classified as a Report Publication Announcement (RPA) rather than the Annual Report (10-K) itself.
2021-02-24 English
Annual Report to shareholders 58 pages 2.1MB
Annual Report Classification · 100% confidence The document is titled 'Annual Financial Report for the year ended 31 December 2020' and contains comprehensive sections typical of an annual report, including a letter from the Chairman and CEO, Directors' Report, Auditor's Independence Declaration, Remuneration Report, consolidated financial statements, notes, Directors' Declaration, and Independent Auditor's Report. The content includes detailed financial data, operational overview, directors' information, and financial condition review. The length is substantial (15,000 characters), indicating it is the full report rather than an announcement or summary. Therefore, this document fits the definition of an Annual Report (10-K). FY 2020
2021-02-24 English
Appendix 4G and Corporate Governance Statement 21 pages 364.8KB
Governance Information Classification · 95% confidence The document is titled 'Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations' and references ASX Listing Rules 4.7.3 and 4.10.3. It is a governance-related disclosure that accompanies the annual report but is not the annual report itself. The document serves as a key to where governance disclosures can be found and confirms compliance with corporate governance recommendations. It explicitly states it is not a substitute for the corporate governance statement or the annual report. The content is focused on governance principles, board charters, and compliance with ASX corporate governance rules. This matches the description of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document is substantive and not a mere announcement or certification, so it is not RNS or RPA. Therefore, the correct classification is CGR with high confidence.
2021-02-24 English
Product Development Update and Outdoor Test Results 6 pages 3.4MB
Regulatory Filings Classification · 95% confidence The document is an ASX release dated 18 February 2021 from Nanoveu Limited, providing a detailed product development update and outdoor test results for their antiviral technology products. It includes descriptions of new product launches, detailed efficacy testing results, and technical appendices on testing standards and procedures. The content focuses on product updates, test outcomes, and company commentary rather than financial results or regulatory compliance filings. There is no indication that this is a financial report, earnings release, management discussion, or regulatory filing. It is a corporate announcement about product development and test results, which fits best under the category of a general regulatory announcement or compliance update. Given the nature and length of the document, and absence of financial data or meeting-related content, the most appropriate classification is Regulatory Filings (RNS).
2021-02-17 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.